Columbia Labs (CBRX) Completes 1.3M Share Offering; Raises $4.1M in Net Proceeds
Columbia Laboratories, Inc. (Nasdaq: CBRX) has raised approximately $4.7 million in gross proceeds to the Company through the sale of approximately 1.3 million shares of its common stock at a price of $3.50 per share in a registered direct offering.
Net proceeds are expected to be approximately $4.1 million after offering-related fees and expenses. Columbia intends to use the net proceeds from the offering for general corporate purposes, including funding its clinical development and other research and development activities, internal and/or collaborative sales, marketing and distribution expenditures, capital expenditures and working capital needs.
Columbia Laboratories, Inc. engages in the research, development, manufacture, and commercialization of women's healthcare and endocrinology products. I
Net proceeds are expected to be approximately $4.1 million after offering-related fees and expenses. Columbia intends to use the net proceeds from the offering for general corporate purposes, including funding its clinical development and other research and development activities, internal and/or collaborative sales, marketing and distribution expenditures, capital expenditures and working capital needs.
Columbia Laboratories, Inc. engages in the research, development, manufacture, and commercialization of women's healthcare and endocrinology products. I
You May Also Be Interested In
- Delcath (DCTH) Prices 13.3M Shares at $1.50/Share, Sees Net Proceeds of $18.4M
- New York Mortgage Trust (NYMT) Prices 2.75M Offering at $6.65/Share
- GeoGlobal Resources (GGR) Files 9.6M Common Shelf for Shareholders
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
